Trial Profile
Prospective, Multicenter, Registry study of Oxaliplatin (Eloxatin)/Fluorouracil based regimen for Chinese Local Advanced or Metastatic Hepatocellular Carcinoma patients ineligible for curative resection and local treatment
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2016
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Oxaliplatin (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 03 May 2016 New trial record